The BRCA1 gene is a tumor suppressor gene that helps repair damaged DNA and prevents uncontrolled cell growth. When this gene has a harmful mutation, your body loses a key defense against breast, ovarian, and several other cancers. Genetic testing can identify these mutations, allowing you and your doctor to make informed decisions about screening and prevention.
What Does the BRCA1 Gene Actually Do in Your Body?
Every cell in your body has two copies of the BRCA1 gene — one from each parent. This gene produces a protein that acts like a repair crew for your DNA. When your DNA gets damaged from normal cell division or environmental factors, the BRCA1 protein helps fix the breaks.
Think of it as a proofreader for your genetic code. Without a working BRCA1 gene, damaged DNA builds up over time. Cells start dividing with errors, and that is how cancer can begin. The BRCA1 gene is especially important in breast and ovarian tissue because these cells divide frequently.
Research published in Nature has shown that BRCA1 is involved in at least three different DNA repair pathways. It does not just do one job. It coordinates multiple repair processes. This is why a single mutation can have such wide-ranging effects on cancer risk.
What Are the Risks of Having a BRCA1 Mutation?
A BRCA1 mutation dramatically increases your lifetime risk for certain cancers. According to the National Cancer Institute, women with a BRCA1 mutation have a 55 to 72 percent chance of developing breast cancer by age 70. For comparison, the average woman in the United States has about a 13 percent lifetime risk.
Ovarian cancer risk is also significantly higher. Women with a BRCA1 mutation have a 39 to 44 percent lifetime risk of ovarian cancer. The general population risk is about 1.3 percent. These numbers come from large studies tracking thousands of families over decades.
Men with BRCA1 mutations face increased risks too. They have a higher chance of developing male breast cancer, though the absolute risk remains low — about 1 to 5 percent. They also have elevated risks for pancreatic cancer and prostate cancer. The Prostate Cancer Foundation notes that BRCA1 mutations are linked to more aggressive prostate cancers that appear at younger ages.
One less-discussed risk is for pancreatic cancer. Studies suggest BRCA1 mutation carriers have a 2 to 3 percent lifetime risk of pancreatic cancer, compared to about 1 percent in the general population. That is a two to threefold increase, though the absolute numbers remain small.
Who Should Consider BRCA1 Genetic Testing?
Genetic testing is not for everyone. The U.S. Preventive Services Task Force recommends testing only for women with a family history suggesting a BRCA mutation. This includes having a close relative with breast cancer before age 50, ovarian cancer at any age, male breast cancer, or multiple family members with breast or ovarian cancer.
People of Ashkenazi Jewish descent have a higher chance of carrying a BRCA1 mutation. About 1 in 40 Ashkenazi Jews carries one of three specific founder mutations, compared to about 1 in 400 in the general population. If you have Ashkenazi ancestry and a family history of breast or ovarian cancer, testing is worth discussing with your doctor.
Testing is also recommended if you have a personal history of breast cancer diagnosed at age 50 or younger, triple-negative breast cancer diagnosed at age 60 or younger, or ovarian cancer at any age. The National Comprehensive Cancer Network publishes detailed guidelines that doctors use to determine who qualifies for testing.
What Does BRCA1 Genetic Testing Involve?
BRCA1 testing is a simple blood or saliva test. A lab looks for harmful mutations in the BRCA1 gene by sequencing your DNA. The test looks at all the coding regions of the gene and the areas where mutations commonly occur.
Results typically take two to four weeks. You will receive one of three possible results: positive for a harmful mutation, negative for known harmful mutations, or a variant of uncertain significance. A variant of uncertain significance means the lab found a change in the gene but does not yet know if it increases cancer risk. This happens in about 2 to 5 percent of tests.
Genetic counseling before and after testing is standard practice. A genetic counselor reviews your family history, explains what results mean, and helps you understand the implications for your relatives. The American College of Medical Genetics and Genomics recommends that all genetic testing be done with pre-test and post-test counseling.
| BRCA1 Test Result | What It Means | What Happens Next |
|---|---|---|
| Positive | Harmful mutation found | Increased screening, prevention options discussed |
| Negative | No harmful mutation found | Risk based on family history, not gene status |
| Variant of Uncertain Significance | Genetic change found but risk unknown | Reclassified over time as more data becomes available |
What Options Do You Have If You Test Positive for BRCA1?
Testing positive for a BRCA1 mutation does not mean you will definitely get cancer. It means your risk is higher than average, and you have options to manage that risk. The main strategies fall into three categories: increased screening, risk-reducing medications, and preventive surgery.
Increased screening means starting mammograms and breast MRIs earlier and doing them more often. The American Cancer Society recommends that women with BRCA1 mutations start breast cancer screening at age 25 to 30. This includes alternating mammograms and breast MRIs every six months. Ovarian cancer screening is less effective, but some doctors recommend transvaginal ultrasounds and blood tests for CA-125 starting at age 30 to 35.
Risk-reducing medications are an option some women choose. Tamoxifen and raloxifene can lower breast cancer risk by about 50 percent in high-risk women. These are selective estrogen receptor modulators that block estrogen’s effects on breast tissue. They do come with side effects including hot flashes and a small increased risk of blood clots.
Preventive surgery offers the largest risk reduction. A prophylactic mastectomy reduces breast cancer risk by about 90 to 95 percent. Prophylactic salpingo-oophorectomy — removal of the ovaries and fallopian tubes — reduces ovarian cancer risk by about 80 to 95 percent. This surgery also lowers breast cancer risk by about 50 percent in premenopausal women because it removes the main source of estrogen.
Some people report that the decision about preventive surgery is the hardest part of learning their BRCA1 status. There is no right answer for everyone. It depends on your age, your family history, whether you want to have children, and your personal comfort with risk.
Common Misconceptions About BRCA1 Testing
A common myth is that a negative BRCA1 test means you have no cancer risk. That is not true. Most breast cancers are not caused by inherited BRCA mutations. Only about 5 to 10 percent of breast cancers are hereditary, and BRCA1 and BRCA2 account for only a portion of those. A negative test means your risk is at the general population level, but that still means a 1 in 8 lifetime risk for breast cancer.
Another misconception is that BRCA1 mutations only matter for women. Men with BRCA1 mutations have real risks, as discussed earlier. They can also pass the mutation to their children. A father with a BRCA1 mutation has a 50 percent chance of passing it to each child, regardless of the child’s sex.
Some people believe that if they test negative for the specific mutation found in their family, they have no increased risk at all. This is actually true in that specific situation. If your mother carries a known BRCA1 mutation and you test negative for that exact mutation, your cancer risk returns to the general population level. This is one of the clearest benefits of family-based testing.
- BRCA1 mutations are not the only genetic cause of breast cancer. BRCA2, PALB2, CHEK2, ATM, and other genes also increase risk.
- Most insurance plans cover BRCA testing when you meet medical criteria based on family or personal history.
- Results can affect your relatives. A positive test means your siblings, children, and parents each have a 50 percent chance of carrying the same mutation.
- Direct-to-consumer tests do not test for all BRCA1 mutations. They typically test for only three common founder mutations and miss many others.
Frequently Asked Questions
How accurate is BRCA1 genetic testing?
Clinical-grade BRCA1 testing is over 99 percent accurate for detecting the mutations it is designed to find. No test detects every possible mutation, which is why genetic counseling is important for interpreting results.
Does insurance cover BRCA1 testing?
Most insurance plans cover BRCA1 testing when you meet medical guidelines based on personal or family history. Medicare and Medicaid also cover testing for qualifying individuals.
Can you get BRCA1 testing without a doctor?
Direct-to-consumer tests are available without a doctor, but they test for a limited set of mutations. Medical guidelines recommend testing through a healthcare provider with genetic counseling for complete and accurate results.
How long does it take to get BRCA1 test results?
Results typically take two to four weeks from the time the lab receives your sample. Some labs offer expedited testing for people undergoing cancer treatment who need results quickly.
